4 Results

People

  1. Aghajanian
    Aghajanian
  2. Iasonos
    Iasonos
  3. Sarasohn
    Sarasohn
  4. Zhou
    Zhou
  5. Konner
    Konner
  6. Makker
    Makker
  7. Friedman
    Friedman
  8. Grisham
    Grisham
  9. Kyi
    Kyi
  10. O'Cearbhaill
    O'Cearbhaill

Groups

  1. Biostatistics Service (4)
  2. Body Imaging Service (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)
  7. Gynecology Disease Management Team (4)
  8. Radiology, Department of (4)
  9. Solid Tumor Oncology Division (4)
  10. Hematologic Malignancies, Division of (2)
  1. "Qin Zhou"
  2. "Journal article"
  3. "Debra Sarasohn"
Formats
  1. Journal Article (4)
Groups
  1. Biostatistics Service (4)
  2. Body Imaging Service (4)
  3. Department of Medicine (4)
  4. Epidemiology and Biostatistics (4)
  5. GDMT, Medicine (4)
  6. Gynecologic Medicine Service (4)

More Groups

People
  1. Alexia Iasonos (4)
  2. Carol Aghajanian (4)
  3. Debra Sarasohn (4)
  4. Qin Zhou (4)
  5. Jason Konner (3)
  6. Vicky Makker (3)

More People

Years
  1. 2024 (1)
  2. 2023 (1)
  3. 2020 (1)
  4. 2014 (1)
Publications
  1. Gynecologic Oncology (4)
Publishers
  1. Elsevier Inc. (4)

Results (4)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 2 trial of zanidatamab in HER2-overexpressed advanced endometrial carcinoma and carcinosarcoma (ZW25-IST-2)
    Journal Article

    Lumish, M.; Chui, M. H.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Cohen, S.; Friedman, C.; Grisham, R.; Konner, J.; Kyi, C.; more...
    Gynecologic Oncology (2024)

    Fulltext@MSK | Save
  • Durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial cancer or endometrial carcinosarcoma: A randomized open-label phase 2 study
    Journal Article

    Rubinstein, M. M.; Doria, E. R.; Konner, J.; Lichtman, S.; Zhou, Q.; Iasonos, A.; Sarasohn, D.; Troso-Sandoval, T.; Friedman, C.; O'Cearbhaill, R.; more...
    Gynecologic Oncology (2023)

    Fulltext@MSK | Save
  • A phase 1 dose-escalation study of intraperitoneal cisplatin, intravenous/intraperitoneal paclitaxel, bevacizumab, and olaparib for newly diagnosed ovarian cancer
    Journal Article

    Cadoo, K. A.; Grisham, R. N.; O'Cearbhaill, R. E.; Boucicaut, N. N.; Henson, M.; Iasonos, A.; Zhou, Q.; Sarasohn, D. M.; Gallagher, J.; Kravetz, S.; more...
    Gynecologic Oncology (2020)

    Fulltext@MSK | Save
  • A multicenter prospective trial evaluating the ability of preoperative computed tomography scan and serum CA-125 to predict suboptimal cytoreduction at primary debulking surgery for advanced ovarian, fallopian tube, and peritoneal cancer
    Journal Article

    Suidan, R. S.; Ramirez, P. T.; Sarasohn, D. M.; Teitcher, J. B.; Mironov, S.; Iyer, R. B.; Zhou, Q.; Iasonos, A.; Paul, H.; Hosaka, M.; more...
    Gynecologic Oncology (2014)

    Fulltext@MSK | Save